STOCK TITAN
  1. Home
  2. Sec-filings
  3. MDCX
  4. [EFFECT] Medicus Pharma Ltd. SEC Filing

[EFFECT] Medicus Pharma Ltd. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 4, 2026 9:00 A.M.
Form: S-3
CIK: 0001997296
Company Name: Medicus Pharma Ltd.
File Number: 333-293091

Source: View Original Filing on SEC EDGAR

Medicus Pharma Ltd

NASDAQ:MDCX

View MDCX Stock Overview →

MDCX Rankings

#6290 Ranked by Market Cap
N/A Ranked by Dividends

MDCX Latest News

Apr 1, 2026
Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset
Mar 30, 2026
Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate
Mar 26, 2026
Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan
Mar 25, 2026
Medicus Pharma Reports Full-Year 2025 Financial Results and Provides Corporate Update
Mar 18, 2026
Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst

MDCX Latest SEC Filings

Apr 1, 2026
[Form 4] Medicus Pharma Ltd. Insider Trading Activity
Apr 1, 2026
[Form 4] Medicus Pharma Ltd. Insider Trading Activity
Apr 1, 2026
[Form 4] Medicus Pharma Ltd. Insider Trading Activity
Apr 1, 2026
[Form 4] Medicus Pharma Ltd. Insider Trading Activity
Apr 1, 2026
[Form 4] Medicus Pharma Ltd. Insider Trading Activity

MDCX Stock Data

13.65M
17.84M
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
W. CONSHOHOCKEN